Reuters -- Australian-listed biotech firm Immuron is in talks with a major pharmaceutical company for the potential development of Immuron's flu treatment and prevention product, the company said on Thursday.
Reuters -- Australian-listed biotech firm Immuron is in talks with a major pharmaceutical company for the potential development of Immuron's flu treatment and prevention product, the company said on Thursday.
